Total Clarity Wealth Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Total Clarity Wealth Management's CDNA Position: Q1 2022 in Review
Total Clarity Wealth Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 62 shares — an estimated $3K sold.
Total Clarity Wealth Management first reported a position in CDNA in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Total Clarity Wealth Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Total Clarity Wealth Management sold 62 CareDx shares in Q1 2022, an estimated $3K.
- Total Clarity Wealth Management first reported a position in CareDx in Q1 2021 and held it in 3 quarters.
- Total Clarity Wealth Management's CareDx position peaked at $4K in Q3 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Total Clarity Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.